23 min listen
From scientist to founder: NMD Pharma’s CEO Thomas Holm Pedersen discusses leadership, innovation, and the future of biotech
From scientist to founder: NMD Pharma’s CEO Thomas Holm Pedersen discusses leadership, innovation, and the future of biotech
ratings:
Length:
18 minutes
Released:
Mar 4, 2024
Format:
Podcast episode
Description
In this next episode of The Heidrick & Struggles Leadership Podcast, Heidrick & Struggles’ Martin Holm speaks to Thomas Holm Pedersen, the CEO of NMD Pharma, a clinical-stage biotech company with novel treatments for neuromuscular disease. Pedersen shares how he, a scientist and former professor, founded the biotech company and became CEO, sharing the capabilities he needed to learn right away. He discusses the foundational strengths that technically experienced CEOs have that nontechnical CEOs may struggle with in leading a biotech, as well as how he keeps up with different aspects of the growth of the organization including fundraising, hiring key talent, and fostering that culture of growth. Finally, he shares his advice for other biotech founders coming from academia and how he sees the future of the biotechnology industry unfolding. Hosted on Acast. See acast.com/privacy for more information.
Released:
Mar 4, 2024
Format:
Podcast episode
Titles in the series (100)
Mastering digital innovation at GE: Heidrick & Struggles’ Mark Livingston speaks with Ashley Haynes, vice president and general manager of global support at GE Digital, the division within General Electric focused on leading the industrial giant into a new era of digitized, cloud-bas... by The Heidrick & Struggles Leadership Podcast